Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-04-04
2006-04-04
Campell, Bruce R. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S078000, C530S324000, C536S023100
Reexamination Certificate
active
07022671
ABSTRACT:
Novel surfactant protein C esters suitable for preparing pharmaceutical compositions for the treatment of infant respiratory distress syndrome and adult respiratory distress syndrome are described.
REFERENCES:
patent: 5874406 (1999-02-01), Schafer et al.
patent: 5876970 (1999-03-01), Benson et al.
patent: 0 458 167 (1991-11-01), None
patent: WO 95/32992 (1995-12-01), None
patent: WO 97/19108 (1997-05-01), None
Nagasawa et al. 1996, Structure and properties of surfactant protein C, J. Med. Chem. vol. 39: 1676-1681.
Johansson, J. 1998, Augmentation of human and rat Lenticular Glutathione in vitro by prodrugs of gamma-L-glutamyl-L-cysteine, Biochimica et Biophysics Acta, 1408: 161-172.
Nagasawa et al. 1996 (J. Med. Chem. vol. 39: 1676-1681).
Johansson, J. 1998, Augmentation of human and rat Lenticular Glutathione in vitro by prodrugs of gamma-L-glutamyl-L-cysteine, Biochimica et Biophysics Acta, 1408: 161-172.
Johannson et al. 1998, Biochimica et Biophysica Acta, vol. 1408, pp. 161-172.
Nagasawa et al. 1996, J. Med. Chem. vol. 39: 1676-1681.
Sturm Ernst
Ulrich Wolf-Rüdiger
Altana Pharma AG
Campell Bruce R.
Chism B. Dell
Goldberg Joshua B.
McGee Sheldon M.
LandOfFree
Surfactant protein C esters does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Surfactant protein C esters, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Surfactant protein C esters will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3534247